Trial to Assess the Efficacy and Safety of Nafamostat Mesilate During Continuous Renal Replacement Therapy

NCT02478242 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Acute Kidney Injury

Interventions

DRUG: Nafamostat mesilate
DRUG: Normal saline

Sponsor

Kyungpook National University Hospital